Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Randomized Evaluation of the TriGuard™ HDH Embolic Deflection Device During Transcatheter Aortic Valve Implantation

NCT02070731 is registered in ClinicalTrials.gov with Keystone Heart as lead sponsor.

NCT NCT02070731
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02070731 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Randomized Evaluation of the TriGuard™ HDH Embolic Deflection Device During Transcatheter Aortic Valve Implantation
Lead sponsor
Keystone Heart
Phase
Not applicable
Overall status
Completed
Start date
February 28, 2014
Completion date
April 30, 2015
Enrollment
86 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve stenosis